BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 91 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,000 | -40.0% | 5,934 | 0.0% | 0.00% | – |
| Q1 2019 | $20,000 | +17.6% | 5,934 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | -54.1% | 5,934 | 0.0% | 0.00% | – |
| Q3 2018 | $37,000 | -15.9% | 5,934 | 0.0% | 0.00% | – |
| Q2 2018 | $44,000 | +29.4% | 5,934 | +13.4% | 0.00% | – |
| Q1 2018 | $34,000 | -41.4% | 5,235 | -24.7% | 0.00% | – |
| Q4 2017 | $58,000 | -27.5% | 6,948 | 0.0% | 0.00% | – |
| Q3 2017 | $80,000 | +19.4% | 6,948 | +21.2% | 0.00% | – |
| Q2 2017 | $67,000 | +15.5% | 5,733 | +20.8% | 0.00% | – |
| Q1 2017 | $58,000 | -14.7% | 4,746 | -3.8% | 0.00% | – |
| Q4 2016 | $68,000 | +21.4% | 4,932 | +72.7% | 0.00% | – |
| Q3 2016 | $56,000 | +55.6% | 2,856 | 0.0% | 0.00% | – |
| Q2 2016 | $36,000 | – | 2,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |